January 3, 2018
Trends in OTC pharma packaging
While physically over-the-counter (OTC) medicine packaging may mirror the prescription drug market, with continued strong demand for plastic primary pharmaceutical…
Pharmaceuticals, Biotechnology and Life Sciences
Tag: Sanofi
December 18, 2017
Sanofi and Alnylam apply to the European Medicines Agency for patisiran for the treatment of hereditary ATTR amyloidosis
Sanofi Genzyme, the specialty care global business unit of Sanofi, and Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the RNAi therapeutics company,…
December 4, 2017
Sanofi’s Toujeo neet main objective in head-to-head study versus insulin degludec
Sanofi’s Toujeo met the primary study objective in the first large head-to-head clinical trial, called BRIGHT study, comparing Toujeo with insulin…
November 29, 2017
Sanofi to ask for updates information on dengue vaccine
Sanofi said on Wednesday it would ask health authorities to update information provided to physicians and patients on its dengue…
November 10, 2017
Sanofi develops Principa’s drug for multiple sclerosis
Sanofi will develop Principia Biopharma`s experimental oral treatment that could tackle multiple sclerosis (MS) and, maybe other central nervous system…
November 2, 2017
Sanofi Q3 sales up, business net income $2,141
Sanofi’s Q3 2017 sales performance were supported by Sanofi Genzyme, Sanofi Pasteur and Emerging Markets, and it saw net sales…
October 25, 2017
Sanofi sues Mylan in the USA
Sanofi said Tuesday it filed a patent infringement suit against Mylan in the USA, alleging infringement of 18 patents in its…
October 3, 2017
Sanofi appoints new EVP Diabetes & Cardiovascular
Sanofi has appointed Stefan Oelrich as Executive Vice President Diabetes & Cardiovascular (DCV), effectively immediately.
September 28, 2017
European Comission OKs Sanogi’s, Regeneron’s dermatitis treatment Dupixent
Sanofi and Regeneron Pharmaceuticals got European Commission marketing authorization for Dupixent for use in adults with moderate-to-severe atopic dermatitis (AD)…
September 21, 2017
Sanofi, Alnylam’s ATTR amyloidosis study meets main goal
Sanofi’s speciality care unit Genzyme together with an RNAi therapeutics company Alnylam Pharmaceuticals, announced Wednesday that the APOLLO Phase 3…